Intellipharmaceutics International (IPCIF) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free IPCIF Stock Alerts $0.06 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Intellipharmaceutics International Short Interest DataCurrent Short Volume17,600 sharesPrevious Short Volume22,900 sharesChange Vs. Previous Month-23.14%Dollar Volume Sold Short$1,056.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 30, 2024Outstanding Shares33,090,000 sharesPercentage of Shares Shorted0.05%Today's Trading Volume0 sharesAverage Trading Volume6,473 sharesToday's Volume Vs. Average0% Short Selling Intellipharmaceutics International ? Sign up to receive the latest short interest report for Intellipharmaceutics International and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIPCIF Short Interest Over TimeIPCIF Days to Cover Over TimeIPCIF Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s PRIME is Set to Shock the WorldMust-See: Elon's New Invention is Absolutely Insane When you click here and see what Elon Musk’s new invention does…You will NOT believe it. But Elon just tested this in a real human… And the result was mind-blowing.Click here for the full story… Intellipharmaceutics International Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202417,600 shares $1,056.00 -23.1%N/A0.7 $0.06 4/15/202422,900 shares $1,374.00 -19.9%N/A2.5 $0.06 3/31/202428,600 shares $2,035.18 +2,760.0%N/A1.2 $0.07 3/15/20241,000 shares $25.50 +100.0%N/A0.2 $0.03 2/29/2024500 shares $23.25 No ChangeN/A0.1 $0.05 2/15/2024500 shares $27.00 -84.9%N/A0.1 $0.05 Get the Latest News and Ratings for IPCIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,500 shares $177.45 +9.4%N/A0.2 $0.05 12/31/20233,200 shares $205.44 -61.5%N/A0.1 $0.06 12/15/20238,300 shares $605.07 +3.8%N/A1.5 $0.07 11/30/20238,000 shares $340.00 +166.7%N/A1.5 $0.04 11/15/20233,000 shares $161.40 No ChangeN/A3.8 $0.05 10/31/20233,000 shares $161.10 No ChangeN/A1.8 $0.05 10/15/20233,000 shares $210.00 No ChangeN/A0.1 $0.07 9/30/20233,000 shares $244.50 -6.3%N/A3.3 $0.08 9/15/20233,200 shares $228.80 -3.0%N/A0.6 $0.07 8/31/20233,300 shares $260.37 No ChangeN/A0.4 $0.08 8/15/20233,300 shares $312.18 +6.5%N/A0.2 $0.09 7/31/20233,100 shares $310.00 -62.7%N/A0.1 $0.10 7/15/20238,300 shares $397.57 No ChangeN/A1.4 $0.05 6/30/20238,300 shares $357.52 +1,560.0%N/A1.4 $0.04 6/15/2023500 shares $27.75 No ChangeN/A0 $0.06 5/31/2023500 shares $30.00 No ChangeN/A0.1 $0.06 5/15/2023500 shares $10.00 No ChangeN/A0 $0.02 4/30/2023500 shares $27.50 No ChangeN/A0.2 $0.06 4/15/2023500 shares $30.00 -88.9%N/A0.2 $0.06 3/31/20234,500 shares $243.23 +462.5%N/A0.3 $0.05 3/15/2023800 shares $44.80 -46.7%N/A0.2 $0.06 2/28/20231,500 shares $75.30 +7.1%N/A0.3 $0.05 2/15/20231,400 shares $85.40 +180.0%N/A0.6 $0.06 1/31/2023500 shares $37.08 No ChangeN/A0.4 $0.07 1/15/2023500 shares $44.50 No ChangeN/A0.3 $0.09 12/30/2022500 shares $35.10 -96.2%N/A0 $0.07 12/15/202213,200 shares $951.72 -5.0%N/A2.4 $0.07 11/30/202213,900 shares $1,000.80 -6.1%N/A2.3 $0.07 11/15/202214,800 shares $1,215.08 +5.7%N/A4.8 $0.08 10/31/202214,000 shares $1,142.40 +45.8%N/A2.4 $0.08 10/15/20229,600 shares $873.60 -25.6%N/A1.1 $0.09 9/30/202212,900 shares $1,056.51 -35.5%N/A1.3 $0.08 9/15/202220,000 shares $1,820.00 +29.0%N/A2.1 $0.09 8/31/202215,500 shares $1,376.40 +72.2%N/A7.8 $0.09CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. IPCIF Short Interest - Frequently Asked Questions What is Intellipharmaceutics International's current short interest? Short interest is the volume of Intellipharmaceutics International shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 17,600 shares of IPCIF short. Learn More on Intellipharmaceutics International's current short interest. What is a good short interest ratio for Intellipharmaceutics International? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPCIF shares currently have a short interest ratio of 1.0. Learn More on Intellipharmaceutics International's short interest ratio. Is Intellipharmaceutics International's short interest increasing or decreasing? Intellipharmaceutics International saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 17,600 shares, a drop of 23.1% from the previous total of 22,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Intellipharmaceutics International's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Intellipharmaceutics International: Galmed Pharmaceuticals Ltd. (1.49%), Allarity Therapeutics, Inc. (10.38%), Qualigen Therapeutics, Inc. (0.80%), CNS Pharmaceuticals, Inc. (0.31%), Clearmind Medicine Inc. (5.51%), Bio-Path Holdings, Inc. (2.85%), Dermata Therapeutics, Inc. (1.28%), PainReform Ltd. (1.17%), Avenue Therapeutics, Inc. (3.26%), 180 Life Sciences Corp. (5.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Intellipharmaceutics International stock? Short selling IPCIF is an investing strategy that aims to generate trading profit from Intellipharmaceutics International as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intellipharmaceutics International? A short squeeze for Intellipharmaceutics International occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPCIF, which in turn drives the price of the stock up even further. How often is Intellipharmaceutics International's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPCIF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Galmed Pharmaceuticals Short Interest Data Allarity Therapeutics Short Interest Data Qualigen Therapeutics Short Interest Data CNS Pharmaceuticals Short Interest Data Clearmind Medicine Short Interest Data Bio-Path Short Interest Data Dermata Therapeutics Short Interest Data PainReform Short Interest Data Avenue Therapeutics Short Interest Data 180 Life Sciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IPCIF) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetry